Search Results
10
Everything
Search Filters
Tag
Oncology
CORRECTION – Global Reach for Biotechs: Avance Clinical Secures MOUs with Four Premier Taiwanese Trial Sites
March 24, 2025 21:51 ET
|
Avance Clinical
Global Reach for US Biotechs: Avance Clinical Secures MOUs with Four Premier Taiwanese Trial Sites
Sermonix and Regor Announce Strategic Collaboration to Optimize Regor’s Proprietary rCARD Platform for Identification of Novel Targets and Therapeutics
March 24, 2025 09:00 ET
|
Sermonix Pharmaceuticals Inc.
COLUMBUS, Ohio and CAMBRIDGE, Mass., March 24, 2025 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals, a privately held biopharmaceutical company developing innovative therapeutics to specifically treat...
Cretostimogene Grenadenorepvec Data Continues to Demonstrate Best-in-Class Durability of Response as well as Consistent and Compelling Safety and Efficacy
March 24, 2025 08:00 ET
|
CG Oncology Inc.
Cretostimogene Grenadenorepvec Data Continues to Demonstrate Best-in-Class Durability of Response as well as Consistent and Compelling Safety and Efficacy
Pasithea Therapeutics to Present at the 2025 CAGLA NeauxCancer Conference
March 24, 2025 06:59 ET
|
Pasithea
Pasithea Therapeutics (KTTA) will present PAS-004 Phase 1 data at the 2025 CAGLA NeauxCancer Conference on March 28 in New Orleans.
Immuneering Corporation Announces Grant of Inducement Award
March 21, 2025 16:30 ET
|
Immuneering Corporation
Immuneering Corporation Announces Grant of Inducement Award
Silexion Therapeutics Announces Completion of Innovative Expanded Development Plan for SIL204 which will be unveiled at the 2025 NeauxCancer Conference
March 21, 2025 08:30 ET
|
Silexion Therapeutics Corp
Grand Cayman, Cayman Islands, March 21, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (“Silexion” or the “Company”), a clinical-stage biotechnology company pioneering RNA interference (RNAi)...
Immuneering Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
March 20, 2025 16:05 ET
|
Immuneering Corporation
Immuneering Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
Teclison, Inc. to Participate in Upcoming Investor Conference
March 20, 2025 14:20 ET
|
Teclison
Teclison will present in the MedInvest Biotech + Pharma Investor Conference March 27, 2025 at 2:05pm ET
CURE Media Group and Oncology Nursing News® announce the 2025 Extraordinary Healer® award finalists and keynote speaker, Amy Robach
March 20, 2025 12:00 ET
|
CURE Media Group
CRANBURY, N.J., March 20, 2025 (GLOBE NEWSWIRE) -- CURE Media Group and Oncology Nursing News® are pleased to announce the finalists for the 2025 Extraordinary Healer® award. This award honors...
Menarini Group Announces Collaboration with VisualDx to Aid in Identifying People Who May Have Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
March 20, 2025 08:30 ET
|
Stemline Therapeutics, Inc.
BPDCN is an aggressive hematologic malignancy with a historically poor prognosisVisualDx is a clinical decision support system used by more than 2,300 hospitals, clinics, and medical schools around...